In this article, we discuss 10 pandemic stocks that are losing value.
The outbreak of the COVID-19 pandemic in the beginning of 2020 triggered a freefall in share prices and the stock market saw historically huge declines across all sectors. Some sectors like aerospace, air and travel, banking, insurance, and energy took the longest to recover from the pandemic lows. However, companies offering online shopping, entertainment, remote education, and telemedicine exploded as people were forced to remain indoors during the peak of the pandemic.
Market Trends During The COVID-19 Pandemic
Trends like advanced electronics, innovative technology, and digital medicine were already on the rise when the COVID-19 pandemic gave them an exorbitant boost. Software as a service (SaaS) offerings also accelerated because a home environment required virtual communication and collaboration. Technology as a theme expanded into the healthcare and consumer discretionary sectors, with greater investments in surgical robotics, cloud-based life sciences, and e-commerce platforms.
Companies like PayPal Holdings, Inc. (NASDAQ:PYPL), Block, Inc. (NYSE:SQ), and Sea Limited (NYSE:SE) were also in focus as digital payments mostly replaced cash payments around the world. Gaming corporations such as Roblox Corporation (NYSE:RBLX), Activision Blizzard, Inc. (NASDAQ:ATVI), and Zynga Inc. (NASDAQ:ZNGA) also benefited from the pandemic immensely.
However, there are famous pandemic stocks which are losing value over time, as they are better suited to a home environment and do not hold the same significance in a post-pandemic world. Some of these companies include Moderna, Inc. (NASDAQ:MRNA), Zoom Video Communications, Inc. (NASDAQ:ZM), and Netflix, Inc. (NASDAQ:NFLX), among others discussed in detail below.
Our Methodology
After a careful assessment of the stocks that exploded during the peak of the COVID-19 pandemic, we selected companies that lost the most over the past six months. We have discussed reasons for the companies declining in value as the pandemic eases.
We have ranked the companies according to the hedge fund sentiment around the holdings, which was gauged from the 924 elite funds tracked by Insider Monkey in the fourth quarter of 2021.
Image By peshkov – Adobe Stock
Pandemic Stocks That Are Losing Value
10. Robinhood Markets, Inc. (NASDAQ:HOOD)
Number of Hedge Fund Holders: 24
Loss in Share Price Over 6 Months as of March 1: 73.54%
Robinhood Markets, Inc. (NASDAQ:HOOD) operates a financial services platform in the United States, allowing users to trade stocks, exchange traded funds, options, commodities, and cryptocurrencies.
During the 2020 stock market crash, Robinhood Markets, Inc. (NASDAQ:HOOD) trading increased as retail investors joined the pandemic-driven investing frenzy. The company went public on the Nasdaq on July 29, 2021, and the stock plunged 73.54% over the last six months.
The earnings and revenue for the third and fourth quarter of 2021 came in below market consensus owing to lighter crypto trading amid the crypto crash of 2022. The management commented on the Q4 results, citing “seasonal headwinds and lower retail trading”.
On February 18, Deutsche Bank analyst Brian Bedell raised the price target on Robinhood Markets, Inc. (NASDAQ:HOOD) to $14 from $12 and kept a Hold rating on the shares. The analyst issued a mid-Q1 outlook for the brokers and asset managers and continues to favor the “rate-sensitive stocks” for at least the next two quarters.
Among the hedge funds tracked by Insider Monkey, 24 funds were bullish on Robinhood Markets, Inc. (NASDAQ:HOOD) in Q4 2021, up from 20 funds in the prior quarter. Cathie Wood loaded up on the stock despite underperformance in the recent months, and ARK Investment Management held roughly 24 million Robinhood Markets, Inc. (NASDAQ:HOOD) shares, worth $423.5 million. Wood’s fund increased its stake in the company by 142% in Q4.
In addition to Moderna, Inc. (NASDAQ:MRNA), Zoom Video Communications, Inc. (NASDAQ:ZM), and Netflix, Inc. (NASDAQ:NFLX), Robinhood Markets, Inc. (NASDAQ:HOOD) is a significant pandemic stock that has plummeted over the last few months.
Here is what Claret Asset Management has to say about Robinhood Markets, Inc. (NASDAQ:HOOD) in its Q4 2021 investor letter:
“Robinhood went public at $38 a share at the end of July of this year. After a one day decline of 8%, it proceeded to rise to a peak of $85 in a matter of 4 days before settling down around $40 in September. Then, we found out that the company does not appear to understand the margin rules that apply to their client’s trades… and got fined by the Securities Exchange Commission. As of today, it is trading below $20, at 57 times earnings, approximately half of its IPO price. Caveat emptor… Buyer beware.”
9. Wix.com Ltd. (NASDAQ:WIX)
Number of Hedge Fund Holders: 29
Loss in Share Price Over 6 Months as of March 1: 62.38%
Wix.com Ltd. (NASDAQ:WIX) operates and markets an on-demand platform that allows users to develop a website or web application. The company’s customers are located across North America, Europe, Latin America, and Asia. Wix.com Ltd. (NASDAQ:WIX) also enables e-commerce, marketing, and email marketing plug-ins for customers.
Wix.com Ltd. (NASDAQ:WIX) helps small businesses build and operate websites, which allowed it to gain popularity amid the COVID-19 pandemic, as small companies and mom-and-pop shops took their operations online. However, due to a period of heightened volatility post-pandemic, the company declined to announce annual guidance for bookings, revenue, and free cash flow. In Q4 2021, Wix.com Ltd. (NASDAQ:WIX) reported net losses and revenue missed consensus estimates.
Atlantic Equities analyst Kunaal Malde downgraded Wix.com Ltd. (NASDAQ:WIX) on March 1 to Neutral from Overweight with a $100 price target.
According to the Q4 database of Insider Monkey, 29 hedge funds held long positions in Wix.com Ltd. (NASDAQ:WIX), up from 25 funds in the preceding quarter. Steadfast Capital Management is the largest stakeholder of the company, with 1.6 million shares worth $265.6 million.
Here is what Baron Asset Fund has to say about Wix.com Ltd. (NASDAQ:WIX) in its Q4 2021 investor letter:
“Wix.com Ltd. (NASDAQ:WIX) is a leading provider of software that small companies utilize to build and operate their websites. Despite encouraging quarterly results that reflected a recovery in new customer additions following the summer slowdown, the company’s shares fell as investors continued to rotate out of e-commerce and cloud companies. We retain conviction in Wix’s long-term opportunity as it serves a large addressable market (small businesses seeking a web presence) with leading product solutions and an attractive, subscription-based revenue model.”
8. Novavax, Inc. (NASDAQ:NVAX)
Number of Hedge Fund Holders: 30
Loss in Share Price Over 6 Months as of March 1: 67.67%
Novavax, Inc. (NASDAQ:NVAX) is a Maryland-based biotechnology company that develops vaccines for infectious diseases. The company also created a vaccine for COVID-19, which is ranked as the fifth globally accepted vaccine, following Pfizer, Moderna, Janssen, and AstraZeneca.
The stock is losing value, and shares dropped around 68% in the last six months, especially as the COVID-19 omicron variant hit and competitors like Pfizer and BioNTech have a huge head start over Novavax, Inc. (NASDAQ:NVAX). However, the company is working on creating vaccine variants to fight omicron.
On February 28, Novavax, Inc. (NASDAQ:NVAX) missed its Q4 2021 results on both the top and bottom lines, and shares traded approximately 7% lower in post-market trading. Novavax, Inc. (NASDAQ:NVAX) was hurt in the fourth quarter by a major increase in R&D expenses. They rose 140% to roughly $963 million compared to the prior-year quarter.
Riley analyst Mayank Mamtani lowered the price target on Novavax, Inc. (NASDAQ:NVAX) on March 2 to $250 from $265. According to the analyst, the Q4 print notably had FY22 revenue guidance, for the first time in the company’s history, of $4 billion-$5 billion, the midpoint of which came in ahead of expectations.
A total of 30 hedge funds were bullish on Novavax, Inc. (NASDAQ:NVAX) at the end of December 2021, down from 35 funds in the previous quarter. RA Capital Management is the largest shareholder of the company, with more than 2 million shares worth $300 million.
7. DraftKings Inc. (NASDAQ:DKNG)
Number of Hedge Fund Holders: 34
Loss in Share Price Over 6 Months as of March 1: 61.49%
DraftKings Inc. (NASDAQ:DKNG) operates as a digital sports entertainment and gaming company in the United States, allowing users daily fantasy sports, sports betting, and iGaming opportunities. DraftKings Inc. (NASDAQ:DKNG) opened on February 18 with a 14.39% drop after the company’s below-consensus EBITDA guidance overshadowed a Q4 revenue beat.
The stock rose to prominence during the pandemic since people indulged in online betting and fantasy sports when they were forced to stay indoors. However, investors are concerned as DraftKings Inc. (NASDAQ:DKNG) spends excessively on sales, marketing, and expansion into new territories. The stock declined 61.49% over the last six months.
Citi analyst Jason Bazinet on February 23 lowered the price target on DraftKings Inc. (NASDAQ:DKNG) to $35 from $40 and kept a Buy rating on the shares following the Q4 results. The change in the target price reflects slightly more active accounts but a lower enterprise value per account, the analyst told investors in a research note. He continues to view DraftKings Inc. (NASDAQ:DKNG) as a leading operator in the “fast-growing” U.S. betting market.
Joseph Ravitch and Jeffrey Sine’s Raine Capital is the biggest stakeholder of DraftKings Inc. (NASDAQ:DKNG) as of Q4 2021, with 11.2 million shares worth over $308 million. Overall, 34 hedge funds were bullish on the stock at the end of December 2021.
Here is what Baron Small Cap Fund has to say about DraftKings Inc. (NASDAQ:DKNG) in its Q4 2021 investor letter:
“Shares of DraftKings Inc. (NASDAQ:DKNG) fell in the quarter, as stocks of online gaming companies were under pressure. Sports betting and i-gaming are rolling out with great fanfare and success across the country; however, investors seem concerned about competition and margins. Most participants are spending heavily on marketing and promotions, which is cutting into margins. We see this as a worthy investment in customer acquisition at a moment in time when revenues are just building. We continue to believe that online sports betting and gaming will be enormous industries, and that DraftKings Inc. (NASDAQ:DKNG) will be a leading player. We think the business will have high margins as it matures. We believe we are underwriting the business conservatively and see much upside in the long term.”
6. Teladoc Health, Inc. (NYSE:TDOC)
Number of Hedge Fund Holders: 39
Loss in Share Price Over 6 Months as of March 1: 48.98%
Teladoc Health, Inc. (NYSE:TDOC) is an American virtual healthcare services firm that rose to the limelight during the pandemic, when patients were advised to stay home unless their illness required immediate medical attention.
Teladoc Health, Inc. (NYSE:TDOC) has declined close to 49% in the last six months and the company experienced slower sales growth, with people venturing out of their homes instead of opting for a virtual healthcare provider as the pandemic has slowed in severity and the infection rate has dropped.
On March 2, Deutsche Bank analyst George Hill stated that Teladoc Health, Inc. (NYSE:TDOC)’s partnership with Amazon is a “very modest win” for Teladoc Health, Inc. (NYSE:TDOC). Patients who use the Amazon devices will be directed to the Teladoc Health, Inc. (NYSE:TDOC) service, and will then have to follow the Teladoc Health, Inc. (NYSE:TDOC) process of registration or enrollment before seeing a provider, Hill told investors in a research note. He kept a Hold rating on Teladoc Health, Inc. (NYSE:TDOC) shares.
In the fourth quarter of 2021, 39 hedge funds were bullish on Teladoc Health, Inc. (NYSE:TDOC), down from 40 funds in the prior quarter. Renaissance Technologies is a prominent shareholder of the company, with a $121.5 million position.
Teladoc Health, Inc. (NYSE:TDOC) declined significantly over the last few months as the pandemic has relatively subsided, just like Moderna, Inc. (NASDAQ:MRNA), Zoom Video Communications, Inc. (NASDAQ:ZM), and Netflix, Inc. (NASDAQ:NFLX).
Here is what Greenhaven Road Capital has to say about Teladoc Health, Inc (NYSE:TDOC) in its Q4 2021 investor letter:
“Teladoc Health (TDOC) – I agree with the common sentiment that we have seen the end of the tailwinds many companies enjoyed due to the massive customer behavior changes necessitated by staying home. Shares of “Covid beneficiaries” have sold off dramatically as a result. The share price of Teladoc Health (TDOC) is down >75% and instead of selling for 20X revenues, they are trading for less than 5X revenues.
What do we get at this reduced price? For starters, unlike many other “Covid beneficiaries,” Teladoc still expects to grow 25-30% per year for the next three years, regardless of progress to a more normalized environment. Is this plausible? For starters, management pre-announced revenues and reaffirmed their projections at the JPMorgan healthcare conference after their big selling season was complete, so there are indications that the company continues to believe. More importantly, the path to continued growth is primarily from selling additional products to existing customers. Over the past ten years,
Teladoc has evolved from being a Zoom solution for doctors to a much broader swath of comprehensive service offerings, including the delivery of mental healthcare, the monitoring of chronic conditions, lab testing, and specialist referrals. Teladoc is a telehealth provider that benefits from a large number of offerings as well as a broad geographic footprint in the U.S. and internationally. This scale enables it to provide a comprehensive solution for a health plan or a company making selections for large groups of patients. The benefits of scale are also realized on the development/product front, where there is a large base of 76M end customers to spread investments across. The net result of their product breadth and technology investments is that the company can provide “whole person care” on a purpose-built technology platform…” (Click here to see the full text)
5. Moderna, Inc. (NASDAQ:MRNA)
Number of Hedge Fund Holders: 43
Loss in Share Price Over 6 Months as of March 1: 62.40%
Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company that creates therapeutics and vaccines to treat infectious and rare diseases, immuno-oncology, cardiovascular diseases, and autoimmune diseases. The stock exploded when Moderna, Inc. (NASDAQ:MRNA) created the COVID-19 vaccine that became one of the four WHO approved vaccines for the pandemic.
Moderna, Inc. (NASDAQ:MRNA) significantly declined in the last few months owing to the broad sell-off in growth stocks, and investors believe that the company has run its course with the COVID-19 vaccine gains. The stock also lost value when the U.S. Supreme Court ruled that the vaccine mandate for large companies by the Biden administration was unconstitutional.
Despite the stock underperforming over the last six months, Moderna, Inc. (NASDAQ:MRNA) reported above consensus earnings and revenue for the quarter ending December 2021. In Q4, 43 hedge funds were bullish on Moderna, Inc. (NASDAQ:MRNA), down from 49 funds in the prior quarter. Theleme Partners held the biggest stake in the company, with more than 5 million shares worth $1.27 billion.
Here is what Carillon Tower Advisers has to say about Moderna, Inc. (NASDAQ:MRNA) in its Q3 2021 investor letter:
“Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The stock proved to be an impressive contributor once again in the quarter, as investors continue to evaluate the potential for future growth driven primarily by the firm’s revolutionary COVID-19 vaccine. Strong global demand for the vaccine may persist for the foreseeable future in order to maintain immunity as well as provide protection against any additional future variants. The potential for the firm’s mRNA technology to be used in a number of other use cases, specifically influenza, could also provide an additional tailwind for future growth.”
4. Zoom Video Communications, Inc. (NASDAQ:ZM)
Number of Hedge Fund Holders: 48
Loss in Share Price Over 6 Months as of March 1: 58.39%
Zoom Video Communications, Inc. (NASDAQ:ZM) is a California-based technology company that provides a video-first communications platform to customers worldwide. The pandemic pushed the stock price to almost $600 per share, as work, education, and social life was conducted virtually via Zoom Video Communications, Inc. (NASDAQ:ZM) during nationwide lockdowns.
Zoom Video Communications (NASDAQ:ZM) shares slipped by 1.5% in pre-market trading on March 1 as analysts weighed in on the company’s fourth-quarter results and slightly disappointing sales outlook. The company expects full-year sales to be between $4.53 billion and $4.55 billion, while Wall Street was looking for revenue of $4.75 billion. As the pandemic has eased and lockdowns are lifted worldwide, Zoom Video Communications (NASDAQ:ZM) has failed to maintain interest from investors as the stock has fallen to pre-COVID valuation levels, despite the continued business growth.
On March 2, Barclays analyst Ryan MacWilliams lowered the price target on Zoom Video Communications (NASDAQ:ZM) to $150 from $245 and kept an Equal Weight rating on the shares.
A total of 48 hedge funds were long Zoom Video Communications (NASDAQ:ZM) in Q4 2021, down from 56 funds in the quarter earlier. ARK Investment Management held the biggest stake in the company, owning close to 7 million shares worth $1.26 billion.
Here is what Artisan Partners has to say about Zoom Video Communications, Inc. (NASDAQ:ZM) in its Q1 2021 investor letter:
“We concluded our campaigns in Zoom Video Communications. We have been paring our position in Zoom for several quarters, anticipating the reduced need for video conferencing as vaccination rates climb and people return to their workplaces. That said, we believe there is a strong case to be made that the pandemic has prompted a permanent inflection in video conferencing’s importance—sustainably higher remote work arrangements, more online learning and less business travel. Furthermore, the company’s dramatically expanded user base (up 485% YoY in Q3) positions it well to cross sell additional services, Zoom Phone in particular. The long-term future remains bright, but we decided to end our successful investment campaign in favor of opportunities in our pipeline with more attractive near-term growth prospects.”
3. DocuSign, Inc. (NASDAQ:DOCU)
Number of Hedge Fund Holders: 49
Loss in Share Price Over 6 Months as of March 1: 59.98%
DocuSign, Inc. (NASDAQ:DOCU) is a California-based company that provides e-signature solutions, allowing businesses and individuals to digitally prepare and sign agreements. The stock gained significant traction during the pandemic, when companies conducted a majority of their business online and utilized DocuSign, Inc. (NASDAQ:DOCU)’s services to manage contracts.
DocuSign, Inc. (NASDAQ:DOCU) declined almost 60% in value over the last six months. Investors sold the stock in December as Q3 results missed expectations, with guidance for Q4 also missing estimates, indicating that the COVID-19 boom for the company was over, since the remote working trend is slowing after lockdowns are lifted. DocuSign, Inc. (NASDAQ:DOCU) has also dropped due to the broader sell-off in SaaS stocks, as investors lower exposure to high growth stocks amid rising rates and a tighter monetary policy.
Morgan Stanley analyst Stan Zlotsky downgraded DocuSign, Inc. (NASDAQ:DOCU) on December 16 to Equal Weight from Overweight with a price target of $165, down from $350. The company’s Q3 results altered his thesis around the durability of growth amid tough comps post-COVID, said Zlotsky, who thinks it will likely take time to refocus on the pre-pandemic basics of selling, build the pipeline, and convert that into growth. The company’s management is also conservative on its Q4 and 2022 guidance.
According to the Q4 database of Insider Monkey, 49 hedge funds were bullish on DocuSign, Inc. (NASDAQ:DOCU), down from 51 funds in the previous quarter. Tiger Global Management is the largest stakeholder of the company, with approximately 7 million shares worth more than $1 billion.
Here is what Polen Focus Growth has to say about DocuSign, Inc. (NASDAQ:DOCU) in its Q4 2021 investor letter:
“We opportunistically purchased a new position in DocuSign amid what we believe is a short-term execution issue. DocuSign dominates the market for electronic signatures and is expanding into adjacent areas like contract lifecycle management, AI-based contract analysis, and e-notary services.
It has 1.1 million customers, including over 160,000 large enterprise and commercial customers. DocuSign’s business consists of almost entirely subscription-based revenue with over 120% net revenue retention rates currently. The business is also profitable and cash generative.
DocuSign has over 350 pre-built integrations with many of the most important software applications from Microsoft, Salesforce.com, Workday, and many others. Their e-signature product is embedded into applications that people use every day. E-signatures were already beginning to replace “wet” signatures pre-COVID but substantially accelerated as workforces became mostly remote in 2020. Once businesses move to e-signatures, they typically do not go back.”
2. Peloton Interactive, Inc. (NASDAQ:PTON)
Number of Hedge Fund Holders: 60
Loss in Share Price Over 6 Months as of March 1: 72.65%
Peloton Interactive, Inc. (NASDAQ:PTON) is a New York-based company that provides interactive fitness products to customers across North America and internationally. The stock hit market highs during the pandemic, as lockdowns and closed gyms pushed more individuals towards physical health, and demand for Peloton Interactive, Inc. (NASDAQ:PTON)’s at-home fitness equipment grew exponentially.
The company’s market value rose to a record high of $49.3 billion in December 2020, but it has since plummeted to around $8.5 billion in January 2022. To meet the pandemic-driven demand, Peloton Interactive, Inc. (NASDAQ:PTON) invested in a new production space worth $400 million, but as gyms and social establishments reopened, the company experienced abundant supply but low demand. Adding to that, the recent supply chain challenges and the exceedingly slow delivery times are turning away potential buyers.
The company also suffered when it had to recall equipment in May and November after several injury complaints surfaced and Peloton Interactive, Inc. (NASDAQ:PTON) received bad PR from mainstream television shows. Resultantly, the stock dropped 72.65% over the past six months.
On February 10, MKM Partners analyst Rohit Kulkarni raised the price target on Peloton Interactive, Inc. (NASDAQ:PTON) to $35 from $30 but kept a Neutral rating on the shares after its Q4 results, updated outlook, and announced management changes.
At the end of December 2021, 60 hedge funds were bullish on Peloton Interactive, Inc. (NASDAQ:PTON), down from 62 funds in the quarter prior. Durable Capital Partners is a notable shareholder of the company, with 5.4 million shares worth $194.3 million.
Here is what Artisan Mid Cap Fund has to say about Peloton Interactive, Inc. (NASDAQ:PTON) in its Q4 2021 investor letter:
“We ended our campaigns in Peloton. Peloton is a connected fitness franchise known for its stationary exercise bikes that provide live and on-demand cycling classes. When we trimmed our position in 1Q21, we believed the stock’s valuation was reflecting relatively aggressive assumptions about post-pandemic membership growth. However, we underestimated just how much growth would slow by midyear. A seemingly slow launch of the new Peloton treadmill combined with meaningful price cuts on the bike are erasing the company’s margin progress of 2020, resulting in meaningful short-term losses. While we remain optimistic about the company’s long-term potential, we harvested our position given the negative profit cycle dynamics.”
1. Netflix, Inc. (NASDAQ:NFLX)
Number of Hedge Fund Holders: 113
Loss in Share Price Over 6 Months as of March 1: 34.37%
Netflix, Inc. (NASDAQ:NFLX) is a digital streaming company that also owns an original production house. The stock gained tremendously during the pandemic when cinemas, entertainment establishments, and outdoor spaces closed and people were forced to stay indoors.
Netflix, Inc. (NASDAQ:NFLX) is an “at-home stock” that recently suffered from disappointing subscriber figures, as disclosed in its Q4 earnings report, and stay-at-home stocks are suffering a correction much like the Nasdaq as a whole. The company said it expects to add just 2.5 million subscribers in the first quarter of 2022, way below the 6.93 million that analysts expected.
On February 18, JPMorgan analyst Doug Anmuth said that Netflix, Inc. (NASDAQ:NFLX) shares “remain controversial” as the in-line Q4 subscribers and “light” Q1 outlook are driving lower growth expectations and increased questions around subscriber penetration, the impact of content, and competition. He reiterated an Overweight rating on the shares with a $605 price target but cautions that the potential subscriber impact from the recent price increase “may lie ahead”.
According to the fourth quarter database of Insider Monkey, 113 hedge funds were long Netflix, Inc. (NASDAQ:NFLX), up from 106 funds in the quarter earlier. Fisher Asset Management is the biggest stakeholder of the company, with 5.4 million shares worth $3.2 billion.
Here is what Pershing Square Capital Management has to say about Netflix, Inc. (NASDAQ:NFLX) in its Q4 2021 investor letter:
“Amidst a volatile market backdrop in 2022, hedging gains provided the capital to fund the purchase of Netflix. World’s leading streaming subscription video-on-demand company. Launched its category-pioneering streaming service in 2007. 222 million global paid subscribers in over 190 countries today. Vast and diverse library of high-quality content. Most Emmy-winning and Oscar-winning TV network / studio of 2021. Industry-leading volume of original content episodes released per quarter. High-performance culture led by a visionary management team. Subscription-based, highly recurring revenues. 26% annual streaming revenue growth and ~360 bps of average annual EBIT margin expansion over the last three years. Modest financial leverage (1.5x Net Debt / EBITDA)…” (Click here to see the full text)
You can also take a look at 10 Energy Stocks to Buy According to Blackstone Group and 10 EV Charging Stocks to Buy Now.
Follow Insider Monkey on Twitter
Suggested articles:
- 15 Most Valuable Japanese Companies in the World
- 10 Best Small Cap Stocks To Buy for 2022
- These 10 Companies Just Increased Their Dividends By Over 10%
Disclosure: None. 10 Pandemic Stocks That Are Losing Value is originally published on Insider Monkey.
